Fingerprint
Dive into the research topics of 'Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRα mutation status'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRα mutation status
Nitin Jain, Jorge Cortes, Alfonso Quintás-Cardama, Taghi Manshouri, Raja Luthra, Guillermo Garcia-Manero, Hagop Kantarjian, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations